logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure EYE-2. Lifetime prevalence for drugs other than cannabis among school student [see all figures in this series...]

Part (iii) Lifetime prevalence of ecstacy use and perceived great risk among 15/16 year olds school (%), 2007


Spain did not participate in the ESPAD survey. The data included here is based on a Spanish survey conducted in 2006/2007. Drug prevalence questions may be considered comparable to the ESPAD questions but other aspects of the method mean that the Spanish data is not strictly comparable. Belgium data is based on Flanders only. German data is based on seven regions only (Bavaria, Brandenburg, Berlin, Hesse, Mecklenburg-Western Pomerania, Saarland and Thuringia). ESPAD 2007 data for Denmark limited comparability.

Prevalence of LTP for use of ecstasy is probably too low to show an association with perceived risk

Perceived great risk is defined as those answering that they think there is a great risk of people risk harming themselves (physically or in other ways) if they: a) try ecstasy once or twice b) take ecstasy regularly

Related links:

Statistical bulletin 2005: Figure EYE-2 part (ii)


ESPAD (The European School Survey Project on Alcohol and Other Drugs) is coordinated by the Swedish Council for Information on Alcohol and Other Drugs (CAN) and Council of Europe (Pompidou Group).

(see the help page for information about formats etc.)

Page last updated: Monday, 31 August 2009